Clinical Trial Update: Intravenous Magnesium Sulfate in Aneurysmal Subarachnoid Haemorrhage (IMASH) [Phase 3]

View source ↗

Summary

Phase 3 trial IMASH evaluating intravenous magnesium sulfate for aneurysmal subarachnoid hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage
• Subarachnoid Hemorrhage

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Subarachnoid Hemorrhage | Phase 3 | Status: COMPLETED